MARY IMOGENE BASSETT HOSPITAL — History
CCN 330136 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$529M
Latest Revenue (FY2022)
+5.9%
Revenue CAGR (3yr)
-31.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $472M | $539M | $529M | -1.9% | +5.9% |
| Operating Expenses | $600M | $634M | $696M | +9.9% | +7.7% |
| Operating Margin | -27.0% | -17.5% | -31.6% | -80.7% | +0.0% |
| Net Income | $-128M | $-94M | $-167M | -77.3% | +0.0% |
| Licensed Beds | 160 | 160 | 160 | +0.0% | +0.0% |
| Total Patient Days | 37,563 | 43,788 | 42,871 | -2.1% | +6.8% |
| Medicare Day % | 41% | 40% | 36% | -8.7% | -6.5% |
| Medicaid Day % | 4% | 2% | 2% | -1.0% | -20.2% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +12.0% ($472M → $529M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.9%
This Hospital
+7.6%
State Avg
Latest Margin
-31.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $558M | -33.9% |
| FY2024 (proj) | $586M | -36.1% |
| FY2025 (proj) | $614M | -38.4% |